IMPLANT
    1.
    发明公开
    IMPLANT 审中-公开

    公开(公告)号:US20240350704A1

    公开(公告)日:2024-10-24

    申请号:US18701733

    申请日:2022-10-20

    IPC分类号: A61L27/10 A61L27/38

    摘要: A method of forming an implant for the repair of defects in bone. the method comprises the steps of: electrospinning bioactive glass fibres: compressing the electrospun bioactive glass fibres to form a compressed body: heating the compressed body to bond the fibres to form a shaped body: heat treating the shaped body to form a heat-treated shaped body. There is also disclosed an implant for use in repairing critical or sub critical bone defects.

    High Fidelity Robust Atom Optics
    2.
    发明公开

    公开(公告)号:US20240319402A1

    公开(公告)日:2024-09-26

    申请号:US18491841

    申请日:2022-04-26

    IPC分类号: G01V7/04 G21K1/00

    CPC分类号: G01V7/04 G21K1/006

    摘要: An apparatus for driving atoms of an atom cloud into a targeted quantum state is provided, the apparatus comprising: an atom source for releasing a cloud of atoms to be driven into a targeted quantum state; a laser system configured to generate a laser beam to be directed onto the atom cloud in use, the laser beam having a frequency corresponding to a resonant frequency of an atomic transition for exciting the atoms into the targeted quantum state; a modulator configured to, in use, modulate the frequency of the laser beam responsive to an input signal; a waveform generator coupled to the modulator and configured to, in use, generate an input signal for the modulator, wherein the input signal is arranged to cause the modulator to modulate the laser light to generate a comb of frequencies around the resonant frequency of the atomic transition, the frequency comb including a plurality of peaks, each peak being separated by a frequency spacing, δω, that is determined based on a Rabi frequency, Ω, of the atomic transition to drive atoms of the atom cloud into a targeted quantum state.

    USES OF CHK2 INHIBITORS
    6.
    发明公开

    公开(公告)号:US20230390283A1

    公开(公告)日:2023-12-07

    申请号:US18032994

    申请日:2021-10-15

    IPC分类号: A61K31/497 A61P25/28

    CPC分类号: A61K31/497 A61P25/28

    摘要: The present disclosure relates to the treatment of neurological conditions, by inhibiting Chk2 kinase. Particular neurological conditions may be associated with neuronal damage/dysfunction or neurological degeneration, which may result from, physical trauma, chemical means, infection, inflammation, hypoxia and/or interruption in blood supply, or be due to a neurodegenerative disorder and/or autoimmune disease. The Chk2 inhibitor may be a small molecule, protein, peptide or nucleic acid. Exemplary small molecule Chk2 inhibitors include PV1019, AZD7762, CCT241533, BML-277 or prexasertib.

    FREQUENCY CONTROL OF ORTHOGONAL POLARISATION MODES IN AN OPTICAL CAVITY

    公开(公告)号:US20230288183A1

    公开(公告)日:2023-09-14

    申请号:US18019573

    申请日:2021-07-19

    摘要: The application discloses an atom interferometer comprising an optical cavity and method of operation thereof. The atom interferometer includes a vacuum chamber, an optical cavity, a source for providing a cloud of atoms in the optical cavity in use, and one or more light sources. The one or more light sources are for generating, in the cavity, in use a first light beam having a first polarisation and at a first frequency for a two-photon interaction in the atoms; and a counterpropagating second light beam having a second polarisation orthogonal to the first polarisation and at a second frequency for the two-photon interaction in the atoms. The atom interferometer also includes an electro-optic element arranged in the cavity to be operable to simultaneously change: the resonant frequency of the cavity for light in the first polarisation to track changes in the frequency of the first light beam to compensate for the doppler shift of the falling atoms in use; and the resonant frequency of the cavity for light in the second polarisation to track changes in frequency of the counterpropagating second light beam to compensate for the doppler shift of the falling atoms in use.

    EPIGENETIC PROFILING METHOD
    9.
    发明申请

    公开(公告)号:US20220389501A1

    公开(公告)日:2022-12-08

    申请号:US17761785

    申请日:2020-09-18

    IPC分类号: C12Q1/6869 C12Q1/6806

    摘要: The present invention relates to a method for analyzing DNA including forming labeled DNA fragments by cleaving genomic DNA into DNA fragments, selectively functionalizing any non-methylated CpG sites present in the DNA with a linker including a hydrolyzable moiety, and attaching a label to the linker. The method further includes the step of separating the labeled DNA fragments from any non-labeled DNA fragments, hydrolyzing the hydrolyzable moiety of the linker of the separated labeled DNA fragments so as to release the DNA fragments from the label, and sequencing the released DNA fragments.

    LABELLING OF BIOMOLECULES
    10.
    发明申请

    公开(公告)号:US20220340946A1

    公开(公告)日:2022-10-27

    申请号:US17761817

    申请日:2020-09-18

    IPC分类号: C12P19/34

    摘要: A method of reversibly labeling a biomolecule including providing a linker molecule (11) having a first functional group (LG) with a reactive center, a second functional group (FG) with a reactive center, and a cleavable, e.g. hydrolyzable, moiety (A-B-C). The method further includes forming a covalent bond between the biomolecule (10) and the reactive center of the first functional group (LG), forming a covalent bond between a first label (L1) and the reactive center of the second functional group (FG), cleaving the cleavable moiety (A-B-C), e.g. hydrolyzing the hydrolyzable moiety, of the linker molecule (11) to remove the first label (L1) and to form a third functional group (W) with a reactive center, and forming a covalent bond between a further molecule and the reactive center of the third functional group (W) to reform the cleavable moiety, e.g. hydrolyzable moiety (A-B-C).